Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Trial Shows Vaccine Induces Chikungunya Immune Response

Aedes aegypti mosquito

Initial findings from a large clinical trial testing a vaccine against the chikungunya virus show the vaccine generates protective antibodies in the vast majority of recipients. . . . → Read More: Trial Shows Vaccine Induces Chikungunya Immune Response

Trial Advances of Dual-Action Cancer Immunotherapy

Breast cancer cell

A clinical trial assessing a synthetic antibody to generate an immediate response and also generate a more durable treatment for solid tumor cancers, advanced to a mid-stage study. . . . → Read More: Trial Advances of Dual-Action Cancer Immunotherapy

FDA Issues Guidance for Opioid Therapy Device Trials

Ambulance at night

The U.S. Food and Drug Administration issued new regulatory guidance for clinical trials of medical devices designed to prevent or treat opioid use disorder. . . . → Read More: FDA Issues Guidance for Opioid Therapy Device Trials

NIH Funds Depression Game Therapy Clinical Trial

Brain activity graphic

A treatment for depression designed as a game for patients will be assessed in a clinical trial conducted by a university psychology lab and funded by National Institutes of Health. . . . → Read More: NIH Funds Depression Game Therapy Clinical Trial

Trial Cleared for Lab-Grown Replacement Knee Cartilage

Knee joint X-ray

A biotechnology company creating living tissue from a person’s stem cells says it received FDA clearance for a clinical trial of its replacement knee cartilage. . . . → Read More: Trial Cleared for Lab-Grown Replacement Knee Cartilage

Cancer Immunotherapy Biotech Issues $80M IPO

Wall Street sign

A biotechnology company designing immunotherapies for solid tumor cancers with a patient’s white blood cells is raising $80 million in its initial public offering or IPO. . . . → Read More: Cancer Immunotherapy Biotech Issues $80M IPO

One-Time Crispr HIV Therapy Given Fast-Track Status

T-cell infected by HIV

A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration. . . . → Read More: One-Time Crispr HIV Therapy Given Fast-Track Status

Trial Underway Testing Engineered Cancer-Killing Viruses

Brain tumor illustration

A clinical trial, testing stem cells for neurons fortified with tumor-killing viruses, administered its first doses to a patient with glioma, an aggressive type of brain cancer. . . . → Read More: Trial Underway Testing Engineered Cancer-Killing Viruses

Drug Maker, Univ. Lab Partner on Neuropeptide Anxiety Trial

Nasal spray

A biopharmaceutical company and university neuroscience lab are collaborating on a clinical trial testing a peptide nasal spray treatment for social anxiety disorder. . . . → Read More: Drug Maker, Univ. Lab Partner on Neuropeptide Anxiety Trial

Trial Underway Testing Dried Plasma for Transfusions

Donated plasma

A clinical trial is recruiting participants to assess the safety and feasibility of a system for spray drying and re-constituting a person’s blood plasma. . . . → Read More: Trial Underway Testing Dried Plasma for Transfusions